Abstract
Although the mechanism of fungal infections, particularly that of opportunistic fungus infections, has been studied extensively, much still remains to be clarified. As is the case for certain bacterial infections, it has long been assumed by numerous investigators that some toxins, enzymes and other metabolites produced in vitro as well as in vivo by pathogenic fungi or their cellular constituents might be responsible for the establishment of fungal infections. However, there are very few papers which deal with isolation and/or characterization of pathogenic fungus-derived toxins, particularly those of high molecular weight, to sufficiently meet various criteria for toxins including etiopathological ability. Likewise, it has been speculated that certain enzymes produced by pathogenic fungi are related to the pathogenesis of infections with the fungi implicated, but no direct evidence has been provided.
It is commonly held by researchers concerned with medical mycology that the lowering of specific and/or nonspecific resistance of a host to pathogenic fungi is a prerequisite for the establishment of infections, particularly opportunistic infections. However, it is also accepted that if a given fungus possesses no parasite factors (e.g. toxigenicity, invasiveness and others), it would be unable to initiate infection even when the host is in a severe immunodeficient state. This is supported by our recent studies working with Saccharomyces cerevisiae and some other so-called nonpathogenic yeasts (unpublished data). Based on these considerations, the author and his co-workers have attempted to isolate several high and low molecular weight toxins in a pure state from virulent strains of Candida albicans and Aspergillus fumigatus as opportunist. Studies have also been made on the etiopathological roles of some successfully isolated toxins in infections with the fungi implicated (46).
In addition to our experimental results, general concepts in fungal toxins, particularly those related to such toxins as isolated in our laboratory are outlined. Since opportunistic fungus infections have created a global problem because of their world-wide prevalence, a sharp demarcation between the so-called pathogenic and nonpathogenic fungi has become vague. Despite this situation, two terms are conventionally used throughout this paper.
Similar content being viewed by others
References
Aldridge, D. C., J. J. Armstrong, R. N. Speake & W. B. Turner. 1967. The cytochalasins, a new class of biologically active mould metabolites. J.C.S. Chem. Comms. 26–27.
Anderson, R. J. 1932. The chemistry of the lipoids of tubercle bacilli. Physiol. Rev. 12: 166–189.
Anderson, R. J. & E. Chargraff. 1929. The chemistry of the lipoids of tubercle bacilli. VI. Concerning tuberculostearic acid and phthionic acid from the acetone-soluble fat. J. Biol. Chem. 85: 77–88.
Ballou, C. E. 1974. Some aspects of the structure, immunochemistry and genetic control of yeast mannans. Advances in Enzymol. 40: 239–270.
Bartels, W. & J. Christopherson. 1970. Einige Eigenschaften der alkalischen Phosphatase von Candida albicans. Hoppe-Seyler's Z. Physiol. Chem. 351: 61–67.
Beneke, E. S., R. W. Wilson & A. L. Rogers. 1968. Extracellular enzymes of Blastomyces dermatitidis. Mycopath. Mycol. Appl. 39: 325–328.
Blank, F., O. Chin, G. Just, D. R. Meraze, M. B. Shimkin & R. Wieder. 1968. Carcinogens from fungi pathogenic for man. Cancer Res. 28: 2276–2281.
Brande, A. L., J. McConnell & H. Douglas. 1960. Fever from pathogenic fungi. J. Clin. Invest. 39: 1266–1276.
Brande, A. L. & J. A. Rock. 1959. The sydrome acute disseminated moniliasis in adults. Arch. Intern. Med. 104: 107–116.
Budzko, D. B. & R. Negroni. 1975. Hemolytic, cytotoxic and complement inactivating properties of extracts of different species of Aspergillus. Mycopathol. 57: 23–26.
Budzko, D. B. & R. Negroni. 1976. Depletion of complement in vivo and in vitro by extracts of Aspergillus fumigatus. Int. Archs. Allergy Appl. Immun. 51: 518–524.
Bussey, H. 1972. Effects of yeast killer factor on sensitive cells. Nature 235: 73–75.
Bussey, H. 1974. Yeast killer factor-induced turbidity changes in cells and sphaeroplasts of a sensitive strain. J. Gen. Microbiol. 82: 171–179.
Bussey, H. & D. Sherman. 1973. Yeast killer factor: ATP leakage and coordinate inhibition of macro-molecular synthesis in sensitive cells. Biochim. Biophys. Acta 298: 868–875.
Bussey, H. & N. Skipper. 1975. Membrane-mediated killing of Saccharomyces cerevisiae by glycoprotein from Torulopsis glabrata. J. Bacteriol. 124: 476–483.
Carter, S. C. 1967. Effects of cytochalasins on mammalian cells. Nature 213: 261–264.
Chattaway, F. W. & F. C. Odds. 1971. An examination of the production of hydrolytic enzymes and toxins by pathogenic strains of Candida albicans. J. Gen. Microbiol. 67: 255–263.
Ciegler, A. 1969. Tremorgenic toxin from Penicillium palitans. Appl. Microbiol. 18: 128–129.
Ciegler, A., S. Kadis & S. J. Ajl (eds.) 1971. Microbial toxins Vol. VI, Fungal toxins. Academic Press, New York & London.
Ciegler, A. & J. I. Pitt. 1970. Survey of the genus Penicillium for tremorgenic toxin production. Mycopath. Mycol. Appl. 42: 119–124.
Cole, B. J., J. W. Kirksey, J. H. Moore, B. R. Blankenship, U. L. Diener & N. D. Davis. 1972. Tremorgenic toxin from Penicillium verruculosum. Appl. Microbiol. 24: 248–256.
Convey, R. D., H. M. Peck & R. J. Towensend. 1966. Recent advances in mycotoxicoses. In: Microbiological deterioration in the tropics. Soc. Chem. Indust. Monograph No. 23, p. 31–44, Soc. Chem. Ind., London.
Costa, A. L., A. Misefari & A. Amato. 1968. On the enzymatic activity of certain fungi. VII. Phosphatase activity on media containing sheep's blood of pathogenic strains of Candida albicans. Atti Societa Peloritana di Scienze fische, matematiche, naturali. VIV: 93–101.
Cutler, J. E., L. Friedman & K. C. Milner. 1972. Biological and chemical characterization of toxic substances from Candida albicans. Infec. Immun. 6: 616–627.
Davey, G. & J. Kalmakoff. 1974. Evidence that the nephrotoxin from the fungus Mortierella wolfii is a protein. Can. J. Microbiol. 20: 1513–1516.
Davey, G., L. O. Simpson & J. Kalmakoff. 1975. Localisation and pathogenicity of Mortierella wolfii toxin in mice. J. Pathol. 117: 33–37.
Davey, G., J. M. B. Smith & J. Kalmakoff. 1973. Purification and properties of a toxin isolated from Mortierella wolfii. Infec. Immun. 8: 882–886.
Dennis, D. L. & C. G. Peterson. 1964. Candida albicans shock. Surg. Forum 15: 36–37.
Dobias, B. 1957. Moniliasis in pediatrics. A. M. A. J. Dis. Child. 94: 234–251,
Faulstich, H. & M. Weckauf-Bloching. 1974. Isolation and toxicity of two cytolytic glycoproteins from Amanita phalloides mushrooms. Hoppe-Seyler's Z. Physiol. Chem. 355: 1489–1494.
Faulstich, H., S. Zobeley & M. Weckauf-Bloching. 1974. Cytolytic properties of phallolysin. Hoppe-Seyler's Z. Physiol. Chem. 355: 1495–1498.
Fink, G. R. & C. A. Styles. 1972. Curing of a killer factor in Saccharomyces cerevisiae. Proc. Nat. Acad. Sci. U.S.A. 69: 2846–2849.
Fujiwara, A., J. W. Landau & V. D. Newcomer. 1970. Preliminary characterization of hemolysin of Rhizopus nigricans. Mycopath. Mycol. Appl. 40: 139–144.
Fujiwara, A., J. W. Landau & V. D. Newcomer. 1970. Hemolytic activity of Rhizopus nigricans and Rhizopus arrhizus. Mycopath. Mycol. Appl. 40: 131–138.
Gander, J. E. 1974. Fungal cell wall glycoproteins and peptido-polysaccharides. Ann. Rev. Microbiol. 28: 103–119.
Gip, L. & G. Palsson. 1970. On the hemolytic activity of geophilic dermatophytes. Mycopath. Mycol. Appl. 40: 221–223.
Glinsukon, T., R. C. Shank, G. N. Wogan & P. M. Newberne. 1975. Acute and subacute toxicity of cytochalasin E in the rat. Toxicol. Appl. Pharmacol. 32: 135–146.
Gortner, R. A. & A. F. Blakeslee. 1914. Observations on the toxin of Rhizopus nigricans. Amer. J. Physiol. 34: 353–367.
Hasenclever, H. F. & W. O. Mitchell. 1963. Endotoxin induced tolerance to toxic manifestation of Candida albicans. J. Bacteriol. 85: 1088–1093.
Hayakawa, S., T. Matsushima, T. Kimura, H. Minato & K. Katagiri. 1968. Zygosporin A, a new antibiotic fron Zygosporium masonii. J. Antibiotics 21: 523–524.
Henrici, A. T. 1939. An endotoxin from Aspergillus fumigatus. J. Immunol. 36: 319–338.
Holder, I. A. & P. Nathan. 1973. Effect in mice of injection of variable Candida albicans and a cell-free sonic extract on circulating platelets. Infec. Immun. 7: 468–472.
Holzapfel, C. W. 1968. The isolation and structure of cyclopiazonic acid, a toxic metabolite of Penicillium cyclopium Westling. Tetrahedron 24: 2101–2109.
Hou, C. T., A. Ciegler & C. W. Hesseltine. 1971. Tremorgenic toxins from penicillia III. Tremortin production by Penicillium species on various agricultural commodities. Appl. Microbiol. 21: 1101–1103.
Isenberg, H. D., J. Allerhand & J. I. Berkman. 1963. An endotoxin-like fraction extracted from the cells of C. albicans. Nature 197: 516–517.
Iwata, K. 1977. Fungal toxins and their role in the etiopathology of fungal infections. In: Recent advances in medical and veterinary mycology (K. Iwata, ed.), p. 15–34, University of Tokyo Press, Tokyo and University Park Press, Chicago.
Iwata, K., K. Uchida & H. Endo. 1967. ‘Canditoxin’, a new toxic substance isolated from a strain of Candida albicans. 1. Relationship between strains and virulence and conditions for toxin substance production. Medicine and Biology 74: 345–350 (in Japan).
Iwata, K. & K. Uchida. 1967. ‘Canditoxin’, a new toxic substance isolated from a strain of Candida albicans. 2. Isolation and purification of the toxic substance. Medicine and Biology 74: 351–355 (in Japan).
Iwata, K. & K. Uchida. 1967. ‘Canditoxin’, a new toxic substance isolated from a strain of Candida albicans. 3. Purification of the toxic substance and physico-chemical properties of the purified toxin. Medicine and Biology 75: 192–195 (in Japan).
Iwata, K. & K. Uchida. 1968. ‘Canditoxin’, a new toxic substance isolated from a strain of Candida albicans. 5. Enzymatic activity with special reference to phosphatase. Medicine and Biology 77: 159–164 (in Japan).
Iwata, K. & K. Uchida. 1971. Denaturation of canditoxin and its relation to phosphatase activation. Medicine and Biology 83: 283–286 (in Japan).
Iwata, K. & K. Uchida. 1977. Cellular immunity in experimental fungus infections in mice: the influence of infections and treatment with a Candida toxin on spleen lymphoid cells. Mykosen (in press).
Iwata, K., K. Uchida, K. Hamajima & A. Kawamura. 1974. Role of canditoxin in experimental Candida infection. In: Symp. on Toxins. J. Med. Sci. Biol. 27: 130–133.
Iwata, K., K. Uchida, H. Yamaguchi & Y. Nozu. 1975. In vivo and in vitro mechanism of action of canditoxin. In: Proc. 1st Intl. Congr. of IAMS, Vol. 4, p. 324–332.
Iwata, K., K. Uchida, H. Yamaguchi & Y. Nozu. 1976. Studies on the toxins produced by Candida albicans with special reference to their etiopathological role. In: Yeasts and yeast-like microorganisms in medical science — Proc. 2nd Intl. Specialized Symposium on Yeasts 1972 Tokyo (K. Iwata, ed.), p. 184–190, University of Tokyo Press, Tokyo.
Iwata, K., A. Matsuda, K. Wakabayashi & N. Fukunaga. 1962. An endotoxin-like substance produced by A. fumigatus. Japan. J. Med. Mycol. 3: 66–73 (in Japan.).
Iwata, K., T. Nagai & M. Okudaira. 1969. Fumigatoxin, a new toxin from a strain of Aspergillus fumigatus. J. South Afr. Chem. Inst. Special issue 12: 131–141.
Iwata, K. & Y. Yamamoto. 1977. Glycoprotein toxins produced by Candida albicans. Proc. 4th Intl. Conference on the Mycoses 1977 Brasilia (in press).
Kadis, S., A. Ciegler & S. J. Ajl. 1971. Algal and fungal toxin. In: Microbial toxins Vol. VII, Academic Press, New York & London.
Kadis, S., A. Ciegler & S. J. Ajl. 1972. Fungal toxins. In: Microbial toxins Vol. VIII, Academic Press, New York & London.
Kim, Y. P., K. Adachi & D. Chow. 1962. Leucine aminopeptidase in Candida albicans. J. Invest. Dermatol. 38: 115–116.
Kind, L. S., P. K. Kaushal & P. Drury. 1972. Fatal anaphylaxislike reaction induced by yeast mannans in nonsensitized mice. Infec. Immun. 5: 180–182.
Kobayashi, G. S. & L. Friedman. 1964. Characterization of the pyrogenicity of Candida albicans, Saccharomyces cerevisiae and Cryptococcus neoformans. J. Bacteriol. 88: 660–666.
Kurup, P. V. 1963. Histochemical demonstration of alkaline phosphatase in Candida. Current Science 32: 408–410.
Lin, J. Y., T. W. Jeng, C. C. Chen, G. Y. Shi & T. C. Tung. 1973. Isolation of a new cardiotoxic protein from the edible mushroom, Volvariella volvacea Nature 246: 524–525.
Lin, J. Y., Y. J. Lin, C. C. Chen, H. L. Wu, G. Y. Shi & T. W. Jeng. 1974. Cardiotoxic protein from edible mushrooms. Nature 252: 235–237.
Mankowski, Z. T. 1957. The experimental pathogenicity of various species of Candida in Swiss mice. Trans New York Acad. Sci. 19: 545–568.
Mankowski, Z. T. 1962. The pathological activity of metabolic products of Candida albicans in newborn mice. Mycopath. Mycol. Appl. 17: 165–174.
Mankowski, Z. T. 1964. Occurrence of brain calcification, iron deposits and tonic-clonic convulsions following experimental infections with Candida albicans. Mycopath. Mycol. Appl. 23: 141–148.
Mankowski, Z. T. 1968. Production of glycoprotein by Candida albicans in a synthetic medium and its influence on the growth of newborn mice. Mycopath. Mycol. Appl. 54: 113–118.
Masler, I., D. Šikl, S. Bauer & J. Sandula. 1966. Extracellular polysaccharide-protein complexes produced by selected strains of Candida albicans (Robin) Berkhout. Folia microbiol. 11: 373–378.
Maule, A. P. & P. D. Thomas. 1973. Strains of yeast lethal to brewery yeasts. J. Invest. Brew. 79: 137–141.
Meister, H., B. Heymer, H. Schäffer & O. Haferkamp. 1977. Role of Candida albicans in granulomatous tissue reactions. I. In vitro degradation of C. albicans and immunospecificity of split products. J. Inf. Dis. 135: 224–234.
Mourad, S. & L. Friedman. 1961. Pathogenicity of Candida. J. Bactoriol. 81: 550–556.
Natori, S. 1977. Toxic cytochalasins. Proc. UJNM Conference on Mycotoxins in Human and Animal Health, College Park, Md., U.S.A. (in press).
Naumov, G. I., L. V. Tyrina, N. I. Buryan & T. I. Naumova. 1973. Wine-making, an ecological niche of type K, killer Saccharomyces. Biol. Nauki 16: 103–107.
Nosál, R., J. Novotný & D. Sikl. 1974. The effect of glycoprotein from Candida albicans on isolated rat mast cells. Toxicon 12: 103–108.
Odds, F. C. & J. C. Hierholzer, 1973. Purification and properties of a glycoprotein acid phosphatase from Candida albicans. J. Bacteriol. 114: 257–266.
Ohmomo, S., M. Sugita & M. Abe. 1973. Isolation of cyclopiazonic acid, cyclopiazonic acid imine and bissecodehydrocyclopizonic acid from the cultures of Aspergillus versicolor (Vuill.) Tiraboschi. J. Agr. Chem. Soc. Japan 47: 57–63 (in Japan.).
Peat, S., W. J. Whelan & T. E. Edwards. 1961. Polysaccharides of baker's yeasts. Part IV. Mannan. J. Chem. Soc. Part 1: 29–34.
Philliskirk, G. & T. W. Young. 1975. The occurrence of killer character in yeast of various genera. Antonie van Leeuwenhoek 41: 147–151.
Pringle, R. B. & R. P. Scheffer. 1967. Multiple host-specific toxins from Periconiacircinata. Phytopathol. 57: 530–534.
Pugh, O. & R. A. Cawson. 1975. The cytochemical localization of phospholipase A and lysophospholipase in Candida albicans. Sabouraudia 13: 110–115.
Rau, E. M., E. B. Tilden & V. L. Koenig. 1961. Partial purification and characterization of the endotoxin from Aspergillus fumigatus. Mycopath. Mycol. Appl. 14: 347–358.
Remold, H., H. Fasold & F. Staib. 1968. Purification and characterization of a proteolytic enzyme from Candida albicans. Biochim. Biophys. Acta 167: 399–406.
Roth, F. J. & W. H. Murphy, Jr. 1957. Lethality of cell-free extract of Candida albicans. Proc. Soc. Exp. Biol. Med. 94: 530–532.
Rutquist, L. 1968. Studies on Aspergillus fumigatus: stability of haemolysin and toxin in crude filtrate. Acta Vet. Scand. 9: 350–363.
Sabin, F. R. 1941. Cellular reactions to fractions from tubercle bacilli. Amer. Rev. Tuber. 44: 415–423.
Sakaguchi, O. & K. Yokota. 1969. Studies on biological characteristics of extracted fractions of several filamentous fungi, especially Aspergillus fumigatus toxins. Japan. J. Bacteriol. 24: 15–21. (in Japanese).
Salemink, C. A., F. Schuring, L. C. P. Kerling & B. Schippers. 1966. The isolation of a phytotoxin from cultures of Didymella applanta (Niessl) sacc. Experientia 22: 248.
Salvin, S. B. 1951. Hemolysin from the yeast-like phase of some pathogenic fungi. Proc. Soc. Exp. Biol. Med. 76: 852–854.
Salvin, S. B. 1952. Endotoxin in pathogenic fungi. J. Immunol. 69: 88–99.
Seelig, M. N. 1966. Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defences. Bact. Rev. 30: 442–459.
Šikl, D., L. Masler, Š. Bauer, J. Šandula, A. Tomšíková & V. Zevázal. 1969. Allergenaktivität der polysaccharidproteinkomplexe von Candida. Z. Immun. Allerg. Klin. Immun. 138: 207–215.
Somers, J. M. & E. A. Bevan. 1969. The inheritance of the killer character in yeast. Genet. Res. 13: 71–83.
Staib, F. 1963. Serum proteins as nitrogen source for yeast like fungi. Sabouraudia 4: 187–193.
Stanley, N. F. 1950. Biological properties of polysaccharide and lipoid fractions from a pathogenic strain of Aspergillus fumigatus. Austral. J. Exp. Biol. Sci. 28: 99–108.
Švec, R. 1974. On the mechanism of action of glycoprotein from Candida albicans. J. Hyg. Epidermiol. Microbiol. Immunol. 18: 373–376.
Tilden, E. B., E. H. Hatlon, S. Frecruans & L. Lombard. 1963. Further studies on the Aspergillus toxins. Mycopath. Mycol. Appl. 20: 3–4.
Tilden, E. B., E. H. Hatlon, S. Freeman, W. H. Williamson & V. L. Koenig. 1961. Preperation and properties of the endotoxins of Aspergillus fumigatus and Aspergillus flavus. Mycopath. Mycol. Appl. 14: 325–346.
Uchida, K. & K. Iwata. 1968. ‘Canditoxin’, a new toxic substance isolated from a strain of Candida albicans. 6. Kinds of the intracellular phosphatases and their fluctuation during the growth of the toxin-producing organism. Medicine and Biology. 77: 165–169 (in Japanese).
Uchida, K. & K. Iwata. 1968. 7. Enzymatic properties of the extracellular alkaline phosphatase. Medicine and Biology. 77: 171–174 (in Japanese).
Uchida, K. & K. Iwata. 1971. The role of protease on canditoxin denaturation. Medicine and Biology. 83: 287–290 (in Japanese).
Uchida, K. & K. Iwata. 1971. Dissociation of canditoxin protein into subunits. Medicine and Biology. 83: 291–295 (in Japanese).
Vodkin, M., F. Katterman & G. R. Fink. 1974. Yeast killer mutants with altered double-stranded ribonucleic acid. J. Bacteriol. 117: 681–686.
Wilson, B. J. & C. H. Wilson. 1964. Toxin from Aspergillus flavus: Production on food materials of a substance causing tremors in mice. Science 114: 177–178.
Wilson, B. J., C. H. Wilson & A. W. Hayes. 1968. Tremorgenic toxin from Penicillium cyclopium grown on food material. Nature 220: 77–78.
Woods, D. R. & E. A. Bevan. 1968. Studies on the nature of the killer factor produced by Saccharomyces cerevisiae. J. Gen. Microbiol. 51: 115–126.
Woods, D. R., J. W. Ross & D. A. Hendry. 1974. A new killer factor produced by a killer sensitive yeast strain. J. Gen. Microbiol. 81: 285–289.
Wynston, L. K. & E. B. Tilden. 1963. Chromatographic purification of Aspergillus endotoxins. Mycopath. Mycol. Appl. 20: 272–283.
Yamazaki, M., H. Fujimoto & T. Kawasaki. 1975. The structure of tremorgenic metabolite from Aspergillus fumigatus (Fres.), fumitremorgin A. Tetrahedron Lett. p. 1241.
Yamazaki, M., S. Suzuki & K. Miyaki. 1971. Tremorgenic toxins from Aspergillus fumigatus (Fres.). Chem. Pharm. Bull. 19: 1739–1740.
Yamazaki, M., K. Susago & K. Miyaki. 1974. The structure of fumitremorgin B (FTB), a tremorgenic toxin from Aspergillus fumigatus (Fres.). J. C. S. Chem. Comm. 408–409.
Yokota, K., H. Shimada, A. Kamaguchi & O. Sakaguchi. 1977. Studies on the toxin of Aspergillus fumigatus. VII. Purification and some properties of hemolytic toxin (Asphemolysin) from culture filtrates and mycelia. Microbiol. Immunol. 21: 11–22.
Yu, R. J., C. T. Bishop & F. P. Cooper. 1967. Structural studies of mannans from Candida albicans (serotypes A and B), Candida parapsilosis, Candida stellatoidea and Candida tropicalis. Canad. J. Chem. 45: 2205–2211.
Zaikina, N. A. 1967. Thechemical nature of coagulase from yeast-like fungi. Vop. Med. Klim. 13: 130–132.
Zaikina, N. A. & N. P. Elinov. 1966. Fungal plasmocoagulase. Mycopath. Mycol. Appl. 35: 10–16.
Zaikina, N. A. & N. P. Elinov. 1966. Mode of action of plasma coagulase obtained from some microbes. Z. Microbiol. Epidemiol. Immunobiol. 43: 58–62.
Zaikina, N. A. & N. P. Elinov. 1969. Influence of fungal plasmocoagulase on some microbial infections. Mycopath. Mycol. Appl. 39: 187–195.
Author information
Authors and Affiliations
Additional information
The author thanks Drs. H. Yamaguchi and K. Uchida, Y. Yamamoto, T. Hiratani, and Y. Nozu for their collaboration during these studies.
Rights and permissions
About this article
Cite this article
Iwata, K. Fungal toxins as a parasitic factor responsible for the establishment of fungal infections. Mycopathologia 65, 141–154 (1978). https://doi.org/10.1007/BF00447185
Issue Date:
DOI: https://doi.org/10.1007/BF00447185